Covaxin
- Africa
Guyana Recognised Bharat Biotech’s Covaxin COVID-19 Vaccine
"#Guyana has recognized #India's indigenous vaccine #COVAXIN-important step forward in the post-COVID partnership between India and Guyana," the Indian Embassy…
Read More » - BioTech
Adar Poonawalla of Serum Institute: Vaccination Drive Require 2 to 3 years to Cover Entire Indian Population
"People do not tend to realise that we are amongst the two most populous countries in the world. A vaccination…
Read More » - LimeLight
CoWIN Portal Reconfigured to Reflect Change in Dose Interval of Covishield to 12-16 weeks
Beneficiaries advised to reschedule appointment for 2nd dose of Covishield in alignment with Enhanced Duration between Two Doses
Read More » - BioTech
Augmentation of Manufacturing Capacity for COVAXIN Production Under Mission COVID Suraksha
Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production…
Read More » - LimeLight
DCGI Approves Phase II/III Clinical Trial of COVAXIN Among Age Group of 2 to 18 Years
Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the…
Read More » - COVID-19
White House’s Dr. Fauci Finds Bharat Biotech’s Covaxin Capable to Fight 617 Variant of COVID
At a very crucial time for India’s fight against COVID, Dr. Anthony Fauci who’s the chief medical adviser to the…
Read More »